All stock lists
Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
Healthcare · Biotechnology
18.59+0.18 (+0.97%)
Insider Score
––Not scored
DNLI Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
DNLI Stock Insider Trading Activity
DNLI stock’s insider trading shows 5 sales on the open market for an estimated $435.30K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chin Peter Scott Other | Sell | 1,654 | $22.29 | $36.87K | 0.8% | 204,538 | Sep 4, 2026 | — | Form 4 |
| Thornberry Nancy Director | Sell | 10,824 | $22.85 | $247.33K | 34.8% | 20,301 | Sep 2, 2026 | — | Form 4 |
| Thornberry Nancy Director | Sell | 615 | $23.74 | $14.60K | 3.0% | 19,686 | Sep 2, 2026 | — | Form 4 |
| Schuth Alexander O. Other | Sell | 2,768 | $23.44 | $64.88K | 1.0% | 278,995 | Sep 1, 2026 | — | Form 4 |
| Watts Ryan J. CEO | Gift | 32,220 | — | — | 1.5% | 2,120,384 | Aug 12, 2026 | — | Form 4 |
| Schuth Alexander O. Other | Sell | 2,857 | $25.07 | $71.62K | 1.0% | 281,763 | Aug 11, 2026 | — | Form 4 |
| Cook Jennifer E. Director | Award | 6,408 | — | — | 24.6% | 32,483 | Jun 3, 2026 | — | Form 4 |
| Baker Brothers Life Sciences LP Director | Award | 6,408 | — | — | 1.9% | 343,275 | Jun 3, 2026 | — | Form 4 |
| Baker Brothers Life Sciences LP Director | Award | 6,408 | — | — | 0.2% | 3,422,366 | Jun 3, 2026 | — | Form 4 |
| Thornberry Nancy Director | Award | 6,408 | — | — | 25.9% | 31,125 | Jun 3, 2026 | — | Form 4 |
| FLATLEY JAY T Director | Award | 6,408 | — | — | 39.5% | 22,628 | Jun 3, 2026 | — | Form 4 |
| Klein Peter S Director | Award | 6,408 | — | — | 23.3% | 33,941 | Jun 3, 2026 | — | Form 4 |
| Krognes Steve E. Director | Award | 6,408 | — | — | 20.2% | 38,202 | Jun 3, 2026 | — | Form 4 |
| Schenkein David P Director | Award | 6,408 | — | — | 42.0% | 21,665 | Jun 3, 2026 | — | Form 4 |
| Van Hauwermeiren Timothy Director | Award | 6,408 | — | — | 60.3% | 17,040 | Jun 3, 2026 | — | Form 4 |
| Watts Ryan J. CEO | Sell | 35,198 | $16.50 | $580.77K | 10.6% | 296,833 | Jan 6, 2026 | — | Form 4 |
| Schuth Alexander O. Other | Sell | 17,218 | $16.50 | $284.10K | 5.7% | 282,828 | Jan 6, 2026 | — | Form 4 |
| Schuth Alexander O. Other | Award | 57,700 | — | — | 23.8% | 300,046 | Jan 3, 2026 | — | Form 4 |
| Watts Ryan J. CEO | Award | 78,960 | — | — | 31.2% | 332,031 | Jan 3, 2026 | — | Form 4 |
| Van Hauwermeiren Timothy Director | Award | 10,632 | — | — | New | 10,632 | Nov 4, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.